These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3003730)

  • 21. Lack of cross sensitivity between captopril and enalapril.
    Jackson B; Maher D; Matthews PG; McGrath BP; Johnston CI
    Aust N Z J Med; 1988 Feb; 18(1):21-7. PubMed ID: 2840055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of hydrochlorothiazide, timolol and enalapril in Ethiopians with essential hypertension.
    Habte B
    Ethiop Med J; 1992 Jul; 30(3):163-7. PubMed ID: 1396619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy].
    Ionescu SD; Sandru V; Leuciuc E; Manea P; Burdujan A; Tovarniţchi S; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):128-31. PubMed ID: 12635373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Enalapril in the treatment of essential arterial hypertension].
    Pérez-Grovas H; Fernández M; Arriaga J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1986; 56(5):379-90. PubMed ID: 3026264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Captopril and enalapril in the treatment of renal hypertension].
    Hasanagić H; Djukanović Lj; Subotić Z; Nesić V; Cavrić G
    Srp Arh Celok Lek; 1990; 118(7-8):285-90. PubMed ID: 2097777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of enalapril in patients with essential hypertension].
    Wang X
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):79-81, 126. PubMed ID: 2209407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
    Irvin JD; Viau JM
    Am J Med; 1986 Oct; 81(4C):46-50. PubMed ID: 3022584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
    Valori C; Gambini G; Canini F; Marinelli M; Rossi S; Pinchi G
    Clin Ter; 1989 Jul; 130(1):37-44. PubMed ID: 2551565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of long-term treatment by the angiotensin I-converting enzyme inhibitor enalapril on renal function and left ventricular hypertrophy in severe essential hypertension.
    Horký K; Widimský J; Král J; Skrha J; Hána V
    Cor Vasa; 1990; 32(5):353-62. PubMed ID: 1981038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of arterial hypertension in the aged subject with a converting enzyme inhibitor: enalapril].
    Forette F; Handfield-Jones R; Henry-Amar M; Fouchard M; Bouchacourt P; Hervy MP; Henry JF; Mesguisch-Billaud E; Alexandre JM
    Presse Med; 1985 Dec; 14(44):2237-41. PubMed ID: 3003729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE inhibitors: enalapril and captopril compared.
    Drug Ther Bull; 1985 Nov; 23(23):89-91. PubMed ID: 2998719
    [No Abstract]   [Full Text] [Related]  

  • 37. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of the acetylcholinesterase inhibitors enalapril and captopril on exercise tolerance in hypertensive patients].
    Lai C; Onnis E; Pirisi R; Orani E; Soro A; Cherchi A
    Cardiologia; 1988 Feb; 33(2):211-5. PubMed ID: 2834061
    [No Abstract]   [Full Text] [Related]  

  • 39. Enalapril as first choice treatment of mild, moderate and severe essential hypertension: results of an open multicentre clinical trial. New Zealand Hypertension Study Group.
    N Z Med J; 1987 Mar; 100(819):137-9. PubMed ID: 2837697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enalapril in hypertension.
    Misra NP; Verma Y; Shah JY
    J Assoc Physicians India; 1992 Jul; 40(7):433-5. PubMed ID: 1484020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.